Lenacapavir sodium Intermediate (N-1) (CAS 2189684-58-8) is supplied by Monuo Chemical for specialty chemical and custom synthesis purchasing. It is also searched as Lenacapavir N-1. Buyers typically look up the product name or CAS when sourcing a defined HIV capsid-inhibitor process intermediate for pharmaceutical R&D.
Key Specifications at a Glance
| Product Name | Lenacapavir sodium Intermediate (N-1) |
|---|---|
| CAS Number | 2189684-58-8 |
| Molecular Formula | C40H34ClF10N7O7S3 |
| Molecular Weight | 1046.38 g/mol |
| Chemical Class | Pharmaceutical intermediate (lenacapavir route) |
| Typical Use Area | API process R&D; lenacapavir synthesis intermediate supply |
| Category | Custom synthesis |
| Documents | COA, TDS, SDS on request |
| Supply Origin | China | Worldwide shipping |
What Is Lenacapavir sodium Intermediate (N-1)?
Lenacapavir sodium Intermediate (N-1) (CAS 2189684-58-8), commonly catalogued as Lenacapavir N-1, is a high-molecular-weight fluorinated heterocyclic intermediate used in routes toward lenacapavir. Molecular formula C40H34ClF10N7O7S3; molecular weight about 1046.38 g/mol. Always match CAS 2189684-58-8 on the batch COA.
Supplier literature describes N-1 as a key intermediate in lenacapavir sodium manufacturing and process-development workflows. Lenacapavir is the HIV capsid inhibitor API associated with this intermediate family in pharmaceutical catalogs. Monuo Chemical supplies Lenacapavir sodium Intermediate (N-1) as a specialty chemical raw material under Custom synthesis, with batch identity documentation (COA / SDS). It is supplied for research and process-development purchasing—not as finished API. Finished-product claims, labeling and local regulatory filings remain the customer’s responsibility. Confirm assay, salt form and stage identity against the batch COA for your intended method.
Synonyms & Search Names
- Lenacapavir sodium Intermediate (N-1)
- Lenacapavir N-1
- Lenacapavir intermediate N-1
- 1H-Cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-acetamide derivative (catalog name)
- CAS 2189684-58-8
Applications
In specialty chemical and custom synthesis projects, Lenacapavir sodium Intermediate (N-1) is commonly reviewed for:
- Lenacapavir / lenacapavir sodium process R&D intermediate supply
- Multi-step pharmaceutical synthesis route development
- Analytical reference and impurity / stage tracking in lenacapavir manufacturing workflows
- Catalog purchasing of CAS-matched API intermediates for laboratory use
Compare related specialty items such as Novobiocin sodium (CAS 1476-53-5) in the same Custom synthesis range.
Handling & Use Notes
- Identity check: Confirm CAS 2189684-58-8, intermediate stage (N-1) and assay on the batch COA before use.
- Storage: Keep sealed, dry and protected from light and heat; follow the batch COA / SDS for any cold-storage requirements.
- Process fit: Verify solubility and compatibility with your coupling / purification strategy before scale-up.
- Safety: Follow the SDS for storage, PPE and waste handling. Use the batch SDS as the controlling safety document.
Need assay or packing discussion? Email [email protected] or use the contact form.
Packaging, Storage & Logistics
| Standard Pack Sizes | 50 g / 100 g bottles; 500 g / 1 kg packs (custom packing available) |
|---|---|
| Storage | Keep sealed, dry and protected from light and heat. Follow the batch COA and SDS |
| Shelf Life | Confirm shelf life on the COA for each lot |
| MOQ | Commercial MOQ discussed per project (often from 50 g); larger packs available on request |
| Lead Time | Stock items often ship promptly; custom pack / large lots typically 7–14 working days |
Quality & Documentation
For Lenacapavir sodium Intermediate (N-1) (CAS 2189684-58-8), Monuo Chemical can provide:
- Certificate of Analysis (COA)
- Technical Data Sheet (TDS) and Safety Data Sheet (SDS)
- CAS / product-name confirmation for your purchase file
- Flexible packing from grams to kilograms
- FOB / CIF / DAP terms as agreed
Our team aims to return technical data and quotations within 24 hours. See also Custom synthesis.
Request a Quote
Share your target assay, pack size and destination. We will confirm availability and documentation for Lenacapavir sodium Intermediate (N-1) CAS 2189684-58-8.
Request a Quote | Email: [email protected]
Frequently Asked Questions
What is Lenacapavir sodium Intermediate (N-1) (CAS 2189684-58-8)?
It is a lenacapavir-route pharmaceutical intermediate (Lenacapavir N-1; C40H34ClF10N7O7S3). Monuo Chemical lists it under Custom synthesis. Match CAS 2189684-58-8 on the batch COA.
Is this finished lenacapavir API?
No. It is an intermediate (N-1) for lenacapavir / lenacapavir sodium process R&D—not finished API. Confirm the correct CAS and stage on your RFQ.
What is the molecular formula and weight?
Molecular formula C40H34ClF10N7O7S3; molecular weight about 1046.38 g/mol. Confirm on the batch COA/TDS.
Where is N-1 typically used?
Typical uses include lenacapavir synthesis route development, stage tracking and intermediate supply for pharmaceutical process R&D. Finished-product claims remain the customer’s responsibility.
What specification do you supply?
Exact assay and grade are confirmed on the Certificate of Analysis for each lot. Share your target specification when you request a quote.
How should the material be stored?
Keep sealed, dry and protected from light and heat. Follow the batch SDS and COA for controlling storage conditions.
How do I request a quotation for CAS 2189684-58-8?
Share target assay, pack size and destination via the Request a Quote page or email [email protected]. We aim to reply within 24 hours.
Which related Custom synthesis products can I review?
You may also review 1,3-Diacetyl-2-imidazolidinone (CAS 5391-40-2) and 5-Vinylpyrrolidone (5-VP) (CAS 7529-16-0), or open the full Custom synthesis catalog.
Related Products
- Novobiocin sodium (CAS 1476-53-5)
- 1,3-Diacetyl-2-imidazolidinone (CAS 5391-40-2)
- 1H-Pyrazole-1-carboxamidine hydrochloride (CAS 4023-02-3)
- View all Custom synthesis
Disclaimer: Information is for specialty chemical raw-material identification and technical reference. This material is supplied for research / process-development use as described on the COA—not as finished drug substance. Finished-product claims and regulatory filings remain the customer’s responsibility. Verify each lot against the supplied COA and SDS. Trade terms are FOB / CIF / DAP as agreed.
